Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > WHAT TO EXPECT TODAY
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(634)
•••
Comment by thorgb1on Jan 19, 2018 1:44pm
68 Views
Post# 27395573

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:WHAT TO EXPECT TODAY

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:WHAT TO EXPECT TODAY
StrongLong wrote:

 

thorgb1 wrote: Anybody know offhand the fully diluted share count for combined CMED-HIP entity? I think it was around 37.5M? Trying to figure out what exchange ratio ACB could support with the issuance of 170M shares which they already have approval for.

 

 

Is there somewhere this 170 million is published officially?

If that number is true, it supports the 37.5 million (combined CMED HIP) at the original offer of 4.5:1 and without the cap. 

so, can we really confirm that 170 million shares approved is a fact???

Yes, definitely need to confirm that number. I believe there was a meeting on Monday, at which time they received strong shareholder support for the issuance of up to XXX shares. 170M is the number I recall, but honestly I can't be 100% on that, and I can't find it anywhere in a release. Also, the share issuance may have included other acquisitions and general purposes as well. Need to confirm this. There were some posts on the ACB board about the meeting from people in attendance, but you have to wade through lots of garbage to find them.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities